MedTrace Logo

Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs

NCT04563247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 970

Last updated 2022-02-15

No results posted yet for this study

Summary

This study is about the current knowledge on the immunological changes observed in various healthcare workers in this part of the world, who remained asymptomatic while working in high exposure areas of COVID-19 infection.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

IgG SARS CoV 2 antibodies

The asymptomatic healthcare workers of high exposure COVID19 areas will be tested for IgG SARS CoV 2 antibodies

Sponsors & Collaborators

  • Lahore General Hospital

    lead OTHER_GOV

Principal Investigators

  • Amina Asif, MPhilMicro · LahoreGeneralHospital.Lahore

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-02-08
Completion
2021-02-08

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04563247 on ClinicalTrials.gov